Cancer Research and Treatment
Cancer Research and Treatment is a research topic within Oncology. Science Explorer counts 8.5k research works in it since 1950. 13.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the application of nanotechnology in the treatment and diagnosis of cancer. It includes studies on nanoparticles, biospectroscopic analysis of cancer cells, development of anti-cancer nano drugs, DNA/RNA interaction, photodynamic therapy, pharmacokinetics, and therapeutic nanomedicine using drug delivery systems. The research also explores the use of synchrotron radiation for various aspects of cancer treatment.
- Nanoparticles
- Cancer Cells
- Biospectroscopic Study
- Anti-Cancer Nano Drugs
- Synchrotron Radiation
- DNA/RNA Interaction
- Photodynamic Therapy
- Pharmacokinetics
- Therapeutic Nanomedicine
- Drug Delivery Systems
- Research works
- 8.5k fractional, since 1950
- In the world top 10%
- 1.2k per year above
- Top-10% rate
- 13.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +48% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Cancer Research and Treatment research?
By volume, India and China publish the most (383 and 293 works in 2022–2025).
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer Research and Treatment research?
By volume in 2022–2025, University of Baghdad publishes the most Cancer Research and Treatment research, followed by Hindu College of Pharmacy and Airlangga University.
By volume, 2022–2025
- 1 University of Baghdad Iraq 14 works
- 2 Hindu College of Pharmacy India 8 works
- 3 Airlangga University Indonesia 8 works
- 4 University of Kufa Iraq 8 works
- 5 All India Institute of Medical Sciences India 8 works
- 6 Chandigarh University India 7 works
- 7 University of Indonesia Indonesia 7 works
- 8 Cairo University Egypt 7 works
- 9 Mustansiriyah University Iraq 6 works
- 10 Chinese Academy of Medical Sciences & Peking Union Medical College China 6 works
Where is Cancer Research and Treatment research done?
The largest centres of Cancer Research and Treatment research in 2022–2025 are Beijing (China), Tehran (Iran), Baghdad (Iraq) and New Delhi (India). Among places with at least 20 works in it, it is an unusually large share of all research in Baghdad and Lahore.
Largest cities, 2022–2025
Where it is the local speciality
- BaghdadIQ · 33.7 works8.1×
- LahorePK · 21.6 works5.8×
Location quotient: how much more of its research is in Cancer Research and Treatment than the world average.
Where is the best place to study Cancer Research and Treatment?
Among universities, judged by research, Hindu College of Pharmacy, University of Baghdad and Airlangga University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Hindu College of Pharmacy India | 59.7 | 4.1% | 39.0× | 8 | +55.0% |
| 2 | University of Baghdad Iraq | 53.5 | 0.8% | 9.3× | 14 | — |
| 3 | Airlangga University Indonesia | 25.0 | 0.0% | 4.5× | 8 | +668.5% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Cancer Research and Treatment research growing?
Output in 2018–2022 was 48% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Cancer Research and Treatment.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.